Paper32707656
Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model.
Nakano Y and 5 others. Int J Mol Sci, 2020. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model. Papers, record 32707656. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32707656
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Burns, Chemical | Major topic |
| Corneal Injuries | Major topic |
| Eye Burns | Major topic |
| PPAR alpha | Major topic |
| PPAR gamma | Major topic |
| Animals | |
| Corneal Neovascularization | |
| Cytokines | |
| Disease Models, Animal | |
| Drug Therapy, Combination | |
| Fenofibrate | |
| Fibrosis | |
| Keratitis | |
| Male | |
| Ophthalmic Solutions | |
| Pioglitazone | |
| RNA, Messenger | |
| Rats | |
| Rats, Wistar |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 19K18859 | Japan Society for the Promotion of Science | PubMed |
Source PubMed
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17681149 | PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. | Cell Metab | 2007 | https://conductscience.org/library/papers/17681149 | PubMed |
| 2 | 12874451 | Lymphatic microvessels in the rat remnant kidney model of renal fibrosis: aminopeptidase p and podoplanin are discriminatory markers for endothelial cells of blood and lymphatic vessels. | J Am Soc Nephrol | 2003 | https://conductscience.org/library/papers/12874451 | PubMed |
| 3 | 8858144 | NF-kappa B: ten years after. | Cell | 1996 | https://conductscience.org/library/papers/8858144 | PubMed |
| 4 | 27713336 | Non-Steroidal Anti-Inflammatory Drugs and Brain Inflammation: Effects on Microglial Functions. | Pharmaceuticals (Basel) | 2010 | https://conductscience.org/library/papers/27713336 | PubMed |
| 5 | 31247081 | Rosiglitazone Treatment Prevents Postoperative Fibrosis in a Rabbit Model of Glaucoma Filtration Surgery. | Invest Ophthalmol Vis Sci | 2019 | https://conductscience.org/library/papers/31247081 | PubMed |
| 6 | 26145225 | Corneal structure and transparency. | Prog Retin Eye Res | 2015 | https://conductscience.org/library/papers/26145225 | PubMed |
| 7 | 18982158 | Macrophage diversity in renal injury and repair. | J Clin Invest | 2008 | https://conductscience.org/library/papers/18982158 | PubMed |
| 8 | 32353564 | Synthesis and evaluation of new 1,2,4-oxadiazole based trans- acrylic acid derivatives as potential PPAR-alpha/gamma dual agonist. | Bioorg Chem | 2020 | https://conductscience.org/library/papers/32353564 | PubMed |
| 9 | 10085162 | Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo. | J Biol Chem | 1999 | https://conductscience.org/library/papers/10085162 | PubMed |
| 10 | 15721857 | Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock. | Cardiovasc Res | 2005 | https://conductscience.org/library/papers/15721857 | PubMed |
| 11 | 17970759 | Effects of combined PPARgamma and PPARalpha agonist therapy on reverse cholesterol transport in the Zucker diabetic fatty rat. | Diabetes Obes Metab | 2008 | https://conductscience.org/library/papers/17970759 | PubMed |
| 12 | 23233252 | Safety and efficacy of the multitargeted receptor kinase inhibitor pazopanib in the treatment of corneal neovascularization. | Invest Ophthalmol Vis Sci | 2013 | https://conductscience.org/library/papers/23233252 | PubMed |
| 13 | 17681144 | Macrophage polarization and insulin resistance: PPARgamma in control. | Cell Metab | 2007 | https://conductscience.org/library/papers/17681144 | PubMed |
| 14 | 9222084 | Cytokine expression in the alkali-burned cornea. | Curr Eye Res | 1997 | https://conductscience.org/library/papers/9222084 | PubMed |
| 15 | 28935121 | Treatment of acute ocular chemical burns. | Surv Ophthalmol | 2018 | https://conductscience.org/library/papers/28935121 | PubMed |
| 16 | 24194635 | An ophthalmic solution of a peroxisome proliferator-activated receptor gamma agonist prevents corneal inflammation in a rat alkali burn model. | Mol Vis | 2013 | https://conductscience.org/library/papers/24194635 | PubMed |
| 17 | 17931953 | Progressive pulmonary fibrosis is mediated by TGF-beta isoform 1 but not TGF-beta3. | Int J Biochem Cell Biol | 2008 | https://conductscience.org/library/papers/17931953 | PubMed |
| 18 | 12746275 | Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. | Endocrinology | 2003 | https://conductscience.org/library/papers/12746275 | PubMed |
| 19 | 26199136 | Stimulation of nuclear receptor peroxisome proliferator-activated receptor-γ limits NF-κB-dependent inflammation in mouse cystic fibrosis biliary epithelium. | Hepatology | 2015 | https://conductscience.org/library/papers/26199136 | PubMed |
| 20 | 9104767 | Chemical injuries of the eye: current concepts in pathophysiology and therapy. | Surv Ophthalmol | 1997 | https://conductscience.org/library/papers/9104767 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42713229 | Fenofibrate in ophthalmology: therapeutic efficacy and mechanisms. | J Pharm Pharm Sci | 2026 | https://conductscience.org/library/papers/42713229 | PubMed |
| 42072091 | Chiglitazar Activates PPAR-α/γ to Suppress Oxidative Stress and Angiogenesis in Corneal Neovascularization. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42072091 | PubMed |
| 41854210 | Nintedanib Eye Drops Inhibit Alkali Burn-Induced Corneal Neovascularization Via RAP1/MEK/ERK Signaling Pathway. | Invest Ophthalmol Vis Sci | 2026 | https://conductscience.org/library/papers/41854210 | PubMed |
| 41640824 | The Mechanistic Role of PPARγ in Wound Healing. | PPAR Res | 2026 | https://conductscience.org/library/papers/41640824 | PubMed |
| 41121132 | Transforming corneal alkali burn treatment: unveiling mechanisms and pioneering therapies from bench to bedside. | J Transl Med | 2025 | https://conductscience.org/library/papers/41121132 | PubMed |
| 40190631 | Unraveling PPARβ/δ nuclear receptor agonists via a drug-repurposing approach: HTVS-based ligand identification, molecular dynamics, pharmacokinetics, and in vitro anti-steatotic validation. | RSC Adv | 2025 | https://conductscience.org/library/papers/40190631 | PubMed |
| 39763659 | The role of PPAR in fungal keratitis. | Front Immunol | 2024 | https://conductscience.org/library/papers/39763659 | PubMed |
| 38993197 | Potential therapeutic effects of peroxisome proliferator-activated receptors on corneal diseases. | Exp Biol Med (Maywood) | 2024 | https://conductscience.org/library/papers/38993197 | PubMed |
| 38802470 | Trimebutine prevents corneal inflammation in a rat alkali burn model. | Sci Rep | 2024 | https://conductscience.org/library/papers/38802470 | PubMed |
| 38638288 | Hypoxia, hypoxia-inducible factors and inflammatory bowel diseases. | Gastroenterol Rep (Oxf) | 2024 | https://conductscience.org/library/papers/38638288 | PubMed |
| 38028511 | Research progress on animal models of corneal epithelial-stromal injury. | Int J Ophthalmol | 2023 | https://conductscience.org/library/papers/38028511 | PubMed |
| 36588740 | Fenofibrate suppresses corneal neovascularization by regulating lipid metabolism through PPARα signaling pathway. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36588740 | PubMed |
| 36445944 | Oral Peroxisome Proliferator-Activated Receptor-α Agonist Enhances Corneal Nerve Regeneration in Patients With Type 2 Diabetes. | Diabetes | 2023 | https://conductscience.org/library/papers/36445944 | PubMed |
| 36305579 | Therapeutic roles of PPARα activation in ocular ischemic diseases. | Histol Histopathol | 2023 | https://conductscience.org/library/papers/36305579 | PubMed |
| 36077171 | Prophylactic Instillation of Hydrogen-Rich Water Decreases Corneal Inflammation and Promotes Wound Healing by Activating Antioxidant Activity in a Rat Alkali Burn Model. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36077171 | PubMed |
| 35687344 | PPAR-α Agonist Fenofibrate Ameliorates Sjögren Syndrome-Like Dacryoadenitis by Modulating Th1/Th17 and Treg Cell Responses in NOD Mice. | Invest Ophthalmol Vis Sci | 2022 | https://conductscience.org/library/papers/35687344 | PubMed |
| 34833044 | PPARα Modulation-Based Therapy in Central Nervous System Diseases. | Life (Basel) | 2021 | https://conductscience.org/library/papers/34833044 | PubMed |
| 33645625 | Defective expression of the peroxisome regulators PPARα receptors and lysogenesis with increased cellular senescence in the venous wall of chronic venous disorder. | Histol Histopathol | 2021 | https://conductscience.org/library/papers/33645625 | PubMed |
| 33504094 | Effects of Selective Peroxisome Proliferator Activated Receptor Agonists on Corneal Epithelial Wound Healing. | Pharmaceuticals (Basel) | 2021 | https://conductscience.org/library/papers/33504094 | PubMed |
| 33086679 | PPARα Agonist Oral Therapy in Diabetic Retinopathy. | Biomedicines | 2020 | https://conductscience.org/library/papers/33086679 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| PPARA | 5465 | PubTator's text mining | https://conductscience.org/library/genes/5465 | NCBI Gene |
| PPARG | 5468 | PubTator's text mining | https://conductscience.org/library/genes/5468 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32707656
GET https://conductscience.org/api/papers/v1/32707656/references?page=2